1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
(
- Contribution to journal › Article
- 2022
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
(
- Contribution to journal › Article
- 2021
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
(
- Contribution to journal › Article
- 2020
-
Mark
Incidence and predictors of severe infections in ANCA-associated vasculitis in a population-based cohort – preliminary results
(
- Contribution to journal › Published meeting abstract
-
Mark
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
(
- Contribution to journal › Article
- 2019
-
Mark
Infections are associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis - a population-based case-control study from southern sweden
2019) The 19th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
- 2017
-
Mark
Cartilage oligomeric matrix protein associates with hepatic inflammation and fibrosis in hepatitis C virus infection
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
(
- Contribution to journal › Article
-
Mark
Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.
(
- Contribution to journal › Letter